112 STAT. 2166 PUBLIC LAW 105-261—OCT. 17, 1998 description of each program and project category under each Cooperative Threat Reduction program element that explains the purpose and intent of the funds requested. SEC. 1308. REPORT ON BIOLOGICAL WEAPONS PROGRAMS IN RUSSIA. (a) REPORT. —Not later than March 1, 1999, the Secretary of Defense shall submit to the congressional defense committees a report, in classified and unclassified forms, containing— (1) an assessment of the extent of compliance by Russia with international agreements relating to the control of biological weapons; and (2) a detailed evaluation of the potential political and military costs and benefits of collaborative biological pathogen research efforts by the United States and Russia. (b) CONTENT OF REPORT. —The report required under subsection (a) shall include the following: (1) An evaluation of the extent of the control and oversight by the Government of Russia over the military and civilianmilitary biological warfare programs formerly controlled or overseen by states of the former Soviet Union. (2) The extent and scope of continued biological warfare research, development, testing, and production in Russia, including the sites where such activity is occurring and the types of activity being conducted. (3) An assessment of compliance by Russia with the terms of the Biological Weapons Convention. (4) An identification and assessment of the measures taken by Russia to comply with the obligations assumed under the Joint Statement on Biological Weapons, agreed to by the United States, the United Kingdom, and Russia on September 14, 1992. (5) A description of the extent to which Russia has permitted individuals from the United States or other countries to visit military and nonmilitary biological research, development, testing, and production sites in order to resolve ambiguities regarding activities at such sites. (6) A description of the information provided by Russia about its biological weapons dismantlement efforts to date. (7) An assessment of the accuracy and comprehensiveness of declarations by Russia regarding its biological weapons activities. (8) An identification of collaborative biological research projects carried out by the United States and Russia for which Cooperative Threat Reduction funds have been used. (9) An evaluation of the political and military utility of prior, existing, and prospective cooperative biological pathogen research programs carried out between the United States and Russia, and an assessment of the impact of such programs on increasing Russian military transparency with respect to biological weapons activities. (10) An assessment of the political and military utility of the long-term collaborative program advocated by the National Academy of Sciences in its October 27, 1997 report, "Controlling Dangerous Pathogens: A Blueprint for U.S. -Russian Cooperation".
Page:United States Statutes at Large Volume 112 Part 3.djvu/336